RELATIONSHIP BETWEEN MENTAL ILLNESS AND MENTAL WELLBEING
Dr Matthew Iasiello, Head of Data and Research Translation, Be Well Co,
SAHMRI (South Australian Health and Medical Research Institute) &
Post Doctoral Researcher, University of Adelaide
RESEARCHER PROFILE
Filmed in Adelaide, South Australian | December 2024
Since 2015, Dr Matthew Iasiello has been working on the development and dissemination of mental wellbeing interventions across the Australian community at the South Australian Health and Medical Research Institute (SAHMRI). His PhD research was designed specifically to strengthen the translational work conducted by SAHMRI, and to solve problems that represented gaps in the literature that were arising when delivering mental wellbeing interventions into the community. The impact and relevance of Dr Iasiello’s work has been demonstrated with invited presentations at international academic conferences, and multiple media stories with significant online engagements.
Dr Iasiello’s research investigates the dual-continua model, an innovative model of mental health. The dual-continua model of mental health suggests that mental illness and mental wellbeing reflect distinct continua, rather than the extreme ends of a single spectrum. This novel conceptualisation of the relationship between mental illness and mental wellbeing has significant implications in the way we promote mental health, and prevent, treat, and recover from mental illness. However, little is known about the evidence validating the model, and whether this evidence supports the implications that have been proposed in the literature.
Dr Iasiello’s PhD project synthesises the relevant evidence supporting the model, provides further evidence of the role of mental wellbeing in the recovery of mental illness, and addresses important limitations in the current assessment of mental wellbeing in the context of psychological distress and mental illness.
He is engaged in the development of mental wellbeing services and products that emerge directly from the new knowledge generated from his PhD, translated into the community via SAHMRI. This has resulted in the development and evaluation of the Be Well Plan (https://www.bewellco.io/bwt), and evidence-based wellbeing intervention (over 5,000 participants since 2020), and the Be Well Tracker https://www.bewellco.io/be-well-plan, a free online assessment platform that Australians can use to assess and monitor their mental health (20,000 users since 2019).
-
Mental wellbeing in rural and regional communities dealing with environmental challenges
Associate Professor Suzie Cosh is a psychologist and clinical researcher. Her work focuses on the intersection of climate change and mental health and she currently leads a body of work that focuses on supporting small rural communities to recover from and prepare for extreme weather events such as bushfires, floods and droughts.
-
Paediatric haemorrhage and airway procedures
Dr Shane George is a paediatric critical care physician working in paediatric emergency medicine and paediatric intensive care at Gold Coast University Hospital. He is the clinical lead for children’s critical care research for Gold Coast Health, and is a Senior Lecturer at The University of Queensland and Griffith University.
Associate Professor George is also an active clinician researcher on topics that span both emergency medicine and PICU practice including safety in emergency intubation, sepsis, haemostatic resuscitation in children and respiratory support therapies.
-
Liver cancer biomarkers, risk prediction & progression
Dr. Rodrigo Carlessi is an expert in Cancer Genomics and Molecular Biology, with an extensive track record in liver cancer research. He leads the Cancer Genomics Group within the Liver Disease and Regeneration Laboratory at the Curtin Medical Research Institute. He has an impressive publication record, with 43 manuscripts that have collectively garnered over 2,680 citations. His research leverages cutting-edge genomics and transcriptomics technologies, as well as long-read DNA sequencing, to explore mechanisms, identify biomarkers, and develop therapeutic targets in liver disease and cancer.
